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 Abstract.  Particular alleles of the  interleukin-1B (IL-1B) gene have been correlated with increased risk of atrophic 
gastritis and gastric cancer in the populations of East Asia and Europe. No such data exist from Peru, a developing coun-
try with a population genotypically different from others studied and with a high prevalence of  Helicobacter pylori infec-
tion and gastric cancer. We conducted a case-control study comparing 334 hospitalized patients with atrophic gastritis or 
gastric cancer with 158 nonatrophic gastritis patients (controls). Conditional logistic regression analysis revealed that an 
increased risk of atrophic gastritis (odds ratio, 5.60) and gastric cancer (odds ratio, 2.36) was associated with the  IL-1B -511 
C allele. Our study is the first to establish this allele as a risk for these conditions. Given the high prevalence of  H. pylori 
and recurrence rate after treatment,  IL-1B -511 single-nucleotide polymorphism analysis may identify those individuals 
who would benefit most from robust  H. pylori eradication efforts in Peru. 
 INTRODUCTION 
 Chronic infection by the gastric pathogen  Helicobacter 
pylori is an early risk factor for gastric cancer, one of the most 
frequently lethal malignancies in Latin America, East Asia, 
and Eastern Europe. 1,2 However, only a small fraction of the 
people infected with  H. pylori develop this disease. 3 
 The development of gastric cancer (GC) is considered to be 
multifactorial and probably conditioned by particular aspects 
of the human genotype and other factors, including nutrition, 
environment, and virulence of infecting  H. pylori strains. 4,5 It 
has recently been suggested that interaction between factors 
related to bacterial virulence and immune response of the 
hosts affects the outcome of  H. pylori infection, which may be 
influenced by polymorphisms in both bacteria and host. 6,7 In 
particular, polymorphisms in  IL-1B and  IL-1RN genes were 
found to be associated with increased risk for developing GC 
owing to an increased  IL-1 beta level in the gastric mucosa in 
response to infection with  H. pylori . 7,8 
 However, reports from different parts of the world concern-
ing association of gene polymorphisms with GC are not con-
sistent, and the primarily Amerindian populations of Latin 
America differ significantly from most other well-studied 
human populations, not only in environment and lifestyle but 
also in human and  H. pylori genotype. 9,10 In Peru, gastric can-
cer is still the leading cause of death for both sexes; however, 
no data exist on whether particular  IL-1B -511 and  IL-1RN 
alleles are associated with development of chronic atrophic 
gastritis (ChAG) or GC in Peruvians. Most Peruvians are of 
low socioeconomic status, have had a chronic  H. pylori infec-
tion since infancy, and are at high risk of GC. 11,12 The purpose 
of this prospective study was to determine whether alleles of 
the cytokine  IL-1B gene (site -511) and of the IL1 receptor 
antagonist ( IL-1RN ) associated with an increased risk of can-
cer in some populations are also associated with an increased 
risk for ChAG or GC in a Peruvian Amerindian population. 
We conducted a case-control study of 658 hospitalized patients 
diagnosed for gastric cancer, atrophic gastritis, or nonatrophic 
gastritis (controls). 
 MATERIALS AND METHODS 
 Patients.  We conducted a hospital-based case-control study 
among 658 hospitalized patients recruited sequentially in 
two municipal hospitals in Lima, Peru, from January 2005 to 
December 2006. Patients with a history of cancer, a pregnancy, 
or a biopsy specimen that was inadequate for histopatho-
logic study were excluded from further analysis ( N = 324). 
Gastric biopsies without gastritis, though typical of modern 
industrialized societies, are a rarity in Peru because of high 
rates of chronic  H. pylori infection (over 90% in adults from 
a low socioeconomic group). Thus, from the 334 subjects that 
were included in our study, we used 158 with nonatrophic 
gastritis (NAG) as our reference control group. For subjects 
with noncardia gastric cancer (intestinal type, n = 92; diffuse 
type, n = 41), controls were matched 1:1, and for cases with 
chronic atrophic gastritis (n = 43), controls were matched 2:1. 
Controls were frequency matched to subjects in age (±10 years), 
gender, and environmental risk factors (house material, water 
preparation, waste removal), because significant differences 
have been found between the groups. 
 All participants gave written consent for participation in 
this research study and were interviewed using a 130-item 
questionnaire that included personal characteristics, environ-
mental risk factors, and personal and family medical history. 
Ethylenediamine-tetraacetic acid (EDTA) blood samples (4 mL) 
were obtained and stored at −20°C for later DNA extraction. 
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 The protocol and consent were approved by the human 
study–ethics committees of The Johns Hopkins School of 
Public Health (Baltimore, MD) and AB PRISMA in Lima, 
Peru. 
 Endoscopy.  All endoscopic examinations were routinely 
performed as described by Soto and others. 13 Two gastric 
biopsies were obtained from the midantrum, two gastric biop-
sies from the midcorpus (lesser and greater curvature), and 
one gastric biopsy from the incisura angularis; gastric biopsies 
were also obtained from each visible lesion. One biopsy from 
each gastric site was subjected to histologic preparation, and 
one biopsy from midcorpus and midantrum was used for 
culture and polymerase chain reaction (PCR). All samples 
were coded for anonymity and accurate recordkeeping. 
 Helicobacter pylori detection.  Helicobacter pylori infection 
was detected in gastric biopsies by culture, silver stain, and PCR 
for urease  (ureB) . Biopsies were considered positive if any of 
the three tests was positive and were considered negative only 
when all three tests were negative. 
 Culture and staining.  One gastric corpus biopsy was homog-
enized, and the tissue suspension was spread on BHI blood 
Agar and on Columbia CNA Agar plates (Becton, Dickinson 
and Co., Sparks, MD) and incubated under microaerobic con-
ditions (O 2 , 5%; CO 2 , 10%; N 2 , 85%) at 37°C for 4 to 7 days, as 
previously described. 13 Visible  H. pylori colonies were iden-
tified by characteristic morphology, a positive urease test, and 
bacterial morphology after Gram staining (Sigma, St. Louis, 
MO). In addition, pathohistologic analysis was performed on 
biopsies from antrum, corpus, and incisura using Warthin-
Starry silver stain, as described previously. 14 
 Polymerase chain reaction.  One biopsy sample from the 
gastric antrum was used for DNA preparation using the 
QIAmp DNA Mini Kit (QIAGEN AG, Basel, Switzerland) 
according to the manufacturer’s instructions to detect  H. pylori 
with PCR. Briefly, PCR was carried out in a 25 μL volume 
containing 10–20 ng of extracted DNA, 0.4 mM of each primer 
specific for a 460 bp segment of the  ureB gene (UreB-sense 
5′-CGT CCG GCA ATA GCT GCC ATA GT-3′ and UreB-
antisense 5′-GTA GGT CCT GCT ACT GAA GCC TTA-3′), 
standard PCR buffer, 0.25 mM of dNTP mix, 2.5 mM of MgCl 2 , 
0.02 U of recombinant  Taq DNA Polymerase (Invitrogen, 
Carlsbad, CA), and 0.1 μg/μL of bovine serum albumin, with 
the following cycling parameters: denaturation at 94°C for 
5 minutes, 35 cycles of 94°C for 1 minute, annealing at 67°C 
for 1 minute, and elongation at 72°C for 1 minute; a final step 
of 5 minutes was used to complete DNA extensions at 72°C. 
The PCR products were electrophoresed in a 2% UltraPure 
(Invitrogen) agarose gel in 1X TAE buffer containing 
0.5 mg/mL ethidium bromide (Fisher Scientific, Fair Lawn, NJ) 
and were visualized using Kodak digital science 1D software 
(Eastman Kodak Company, Rochester, NY) on a Dell work-
station (Dell Computer Corporation, Round Rock, TX). 
 Pathohistology.  One biopsy sample each from the antrum, 
corpus, and incisura were fixed in buffered formalin, embedded 
in paraffin, and stained with hematoxylin and eosin (Sigma). 
An experienced pathologist (JC) examined the coded slides 
without knowledge of the area of origin of the microsection, 
clinical data, or endoscopic characteristics. Grades of gastritis 
were classified according to the updated Sydney Classification 
System 15 and are presented in  Table 1 . 
 Gastric carcinoma patients were subdivided according to 
Lauren’s classification as intestinal type and diffuse type. Each 
subject was diagnosed based on the most severe or pronounced 
finding from the pathohistologic study of the gastric biopsies. 
 IL-1B and  IL-1RN genotyping.  The DNA was extracted 
from gastric biopsy or blood specimens using the QIAmp DNA 
Mini Kit (QIAGEN AG) according to the manufacturer’s 
instructions. The PCRs were performed in a 25 μL reaction 
mixture filled to full volume with PCR water (Sigma). 
 For genotyping the position -511 cytokine  IL-1B gene sin-
gle-nucleotide polymorphism (SNP ), a 305 bp fragment was 
amplified with 0.5 μM of each primer, 5′-TGG CAT TGA TCT 
GGT TCA TC -3′ (sense) and 5′-GTT TAG GAA TCT TCC 
CAC TT -3′ (antisense), using standard PCR protocol (see 
above) and optimized with 1.5 μM of MgCl 2 and 0.06 U of 
recombinant  Taq DNA Polymerase. Cycling parameters were 
denaturation at 95°C for 5 minutes followed by 35 cycles of 
95°C for 30 seconds, 50°C for 30 seconds, 72°C for 30 seconds, 
and a final extension step for 5 minutes at 72°C. Thereafter, 
the PCR products were digested for 18 hours at 37°C with 
10 U of  Ava I enzyme (New England BioLabs, Beverly, MA) 
to distinguish allele T ( Ava I-resistant; one fragment of 305 bp) 
versus allele C ( Ava I-cut: fragments of 115 and 190 bp). The 
digested DNAs were electrophoresed on a 2% agarose gel, 
and data were recorded as detailed previously. 
 Either an intact fragment of 305 bp (allele T) or two frag-
ments of 190 bp and 115 bp (allele C) were obtained using 
electrophoresis. Human genotypes could be homozygous C/C, 
T/T, or heterozygous C/T. 
 The diagnostic variable number of tandem repeat (VNTR) 
marker for  IL-1RN alleles was genotyped by PCR as follows: 
0.5 μM of each primer, 5′-CTC AGC AAC ACT CCT AT- 3′ 
(sense) and 5′-TCC TGG TCT GCA GGT AA- 3′ (antisense), 
were used with the cycling parameters used for  IL-1B -511 
genotyping, but with an annealing temperature of 55°C and 
3 mM of MgCl 2 in the buffer. The  IL-1RN alleles were coded 
 Table 1 
 Characterization of gastritis in the study population 
Characteristic NAG* n (%) ChAG† n (%)  P value
Subjects (n) 158 43
Chronicity of gastritis
L1 58 (36.7) 16 (37.2) 0.17
L2 76 (48.1) 25 (58.1)
L3 24 (15.2) 2 (4.7)
Activity of gastritis
G0 51 (32.3) 24 (55.8) 0.036
G1 40 (25.3) 9 (20.9)
G2 47 (29.7) 7 (16.3)
G3 20 (12.7) 3 (7.0)
Atrophy
No 158 (100.0) 0 < 0.001
Light 0 18 (41.9)
Moderate 0 8 (18.6)
Severe 0 17 (39.5)
Topography of atrophy
Focal 34 (79.1) NA‡
Diffuse 9 (20.9)
Intestinal metaplasia
None 117 (91.4) 13 (30.2) < 0.001
Type I 10 (7.8) 28 (65.1)
Type II–III 1 (0.8) 2 (4.7)
Location of gastritis
Predominant antrum 47 (29.7) 32 (74.4) < 0.001
Predominant corpus 48 (30.4) 7 (16.3)
Antrum and corpus 63 (39.9) 4 (9.3)
 *  Nonatrophic gastritis. 
 †  Chronic atrophic gastritis. 
 ‡  Not applicable. 
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as follows: Allele 1 (four repeats of the 86 bp region, 412 bp 
PCR product), allele 2 (two repeats, 240 bp), and allele 3 (three 
repeats, 326 bp). For statistical analysis, this polymorphism was 
treated as bi-allelic using categories of short-allele (S allele) 
with two repeats (allele 2) and long-allele (L allele) with three 
or more repeats (alleles 1 and 3). 
 Samples assayed by PCR product sequencing were also 
used as positive controls for internal validation of enzyme 
digestion. In addition, one-fifth of the analyzed samples were 
tested again using the same assay, with completely concordant 
results. 
 Statistics.  Data were collected in a computerized database 
using double data entry to ensure accurate recording. Descrip-
tive statistical analysis was calculated, including proportions, 
percentage, means, and standard deviations. Chi-square (χ 2 ) 
and  t test were used to assess differences of frequency distri-
butions among demographic characteristics of the study pop-
ulation. To calculate odds ratios (ORs) and 95% confidence 
intervals (CIs) for  IL-1B -511 and  IL-1RN genotypes, a condi-
tional logistic regression model adjusted for  H. pylori infection 
was applied. Stratification in an unconditional logistic regres-
sion analysis was used to evaluate whether the association 
between the cytokine polymorphisms and gastric cancer risk 
differed by histology type or location where it was diagnosed. 
This study’s dependent variable was the histologic diagnosis. 
 Differences were considered statistically significant if  P < 
0.05. Statistical analysis was performed with SPSS software 
(version 11.5, SPSS Science, Chicago, IL) and SPLUS (version 
2000, Insightful Corporation, Seattle, WA). Hardy-Weinberg 
equilibrium of alleles at individual loci was assessed using the 
program Linkage Disequilibrium Analyzer 1.0 (available at 
 http://www.chgb.org.cn/lda/lda.htm ). 
 RESULTS 
 In total, 334 patients were successfully genotyped for 
the two polymorphisms in the  IL-1 gene cluster. The demo-
graphic comparison of matched cases and controls is summa-
rized in  Table 2 . Although 80.1% of patients were infected with 
 H. pylori , the genotype frequencies in cases and controls did 
not deviate from the Hardy-Weinberg equilibrium ( Table 3 ). 
Distribution of gastritis location and intestinal metaplasia (IM) 
were different between patients diagnosed for NAG and ChAG 
( P < 0.001). ChAG occurred more frequently in the antrum 
region and were more often associated with IM. No significant 
differences were revealed between both groups (NAG, ChAG) 
with regard to the chronicity of gastritis ( P = 0.17) ( Table 1 ). 
 Association between polymorphisms of  IL-1 gene cluster 
and the risk of chronic atrophic gastritis.  We found that 
subjects with the C allele of the  IL-1B -511 SNP had a higher 
frequency of atrophic gastritis (OR, 5.60; 95% CI, 2.02–15.51) 
than did subjects with nonatrophic gastritis homozygous for 
the T allele. Also subjects with the C allele homozygote had 
this premalignant lesion more frequently (OR, 11.22; 95% CI, 
2.27–55.37) than did subjects with C/T heterozygotes (OR, 
4.79; 95% CI, 1.65–13.83) ( Table 4 ). We also found a higher 
frequency of chronic atrophic gastritis in the antrum region in 
C/C homozygous subjects (OR, 12.72; 95% CI, 2.12–76.43) than 
in subjects with T/T homozygotes ( Table 6 ). This association 
has not been revealed for corpus region ChAG. Furthermore, 
none of the  IL-1RN VNTR states were associated with 
increased frequency of chronic atrophic gastritis ( Table 4 ). 
 Association between polymorphisms of  IL-1 gene cluster 
and the risk of gastric cancer.  Carriage of the C allele of the 
 IL-1B -511 SNP either in homozygous or heterozygous 
condition was more frequent in subjects with GC than in 
controls (OR, 4.15; 95% CI, 1.33–12.93 and OR, 2.17; 95% CI, 
1.23–3.84, respectively) ( Table 5 ), mirroring the association 
seen between premalignant chronic atrophic gastritis and 
IL-1B SNP. Stratification by location and histologic type 
showed that the C allele was associated with intestinal but 
not with diffuse types of GC. Homozygosity for the C allele in 
particular was associated with a 6-fold increased frequency of 
intestinal GC in the gastric corpus compared with nonatrophic 
gastritis controls (OR, 6.29; 95% CI, 1.17–33.76) ( Table 6 ). 
 None of the  IL-1RN alleles showed particular associations 
with GC, nor was a higher frequency of GC or chronic-atro-
phic gastritis seen with any combination of  IL-1B -511 and 
 IL-1RN alleles (data not shown). 
 DISCUSSION 
 Given a high rate of infection by virulent (CagA positive, 
VacA toxigenic)  H. pylori strains in the Amerindian Peruvian 
population, 9 it has seemed likely that host genetic factors affect 
the risk of emergence and progression of premalignant lesions 
(chronic atrophic gastritis) in  H. pylori -infected Peruvians, as 
in other populations. Here, we found that homozygosity for 
the C allele of the  IL-1B -511 SNP was strongly associated with 
chronic atrophic gastritis (OR, 11.22) and GC (OR, 4.15), even 
 Table 2 
 Demographic variables of matched cases and controls with different diagnoses 
 *  Controls are matched 2:1 (**1:1) to cases according age (± < 10 years), sex, and environmental risk factors. 
 †  Nonatrophic gastritis. 
 ‡  Chronic atrophic gastritis. 
 §  Gastric cancer. 
Patients for ChAG risk analysis Patients for GC risk analysis
Variable NAG*† ChAG*‡  P value NAG** GC**§  P value
Subjects (n) 86 43 133 133
Sex [male/female (%/%)] 52/34 (60.5/39.5) 26/17 (60.5/39.5) 1.0 61/72 (45.9/54.1) 61/72 (45.9/54.1) 1.0
Mean age ± SD (y) 64.0 (14.43) 67.2 (12.73) 0.85 61.4 (14.84) 64.0 (14.76) 0.2
 H. pylori infection (%) 88.4 76.7 0.12 88.0 74.4 0.006
Hospital
Loyaza 63 (73.3) 28 (65.1) 96 (72.2) 80 (60.2)
INEN 23 (26.7) 15 (34.9) 0.41 37 (27.8) 53 (39.8) 0.052
Location
Antrum 61 (70.9) 36 (83.7) 95 (71.4) 70 (52.6)
Corpus 25 (29.1) 7 (16.3) 0.09 38 (28.6) 63 (47.4) 0.002
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 Table 4 
 Conditional logistic regression analysis for the risk of chronic atrophic 
gastritis using nonatrophic gastritis subjects as control 
 Controls and cases are matched 2:1 for age, sex, and environmental factors. 
 *  Nonatrophic gastritis (controls). 
 †  Chronic atrophic gastritis (cases). 
 ‡  Conditional logistic regression model adjusted for  H. pylori infection. 
 §  Subjects with genotype C/T or C/C. 
 ¶  Subjects with genotype *2/L or *2/*2. 
NAG* ChAG†
Genotype  n (%)  n (%) OR (95% CI)‡  P value‡
IL-1B-511
T/T 55 (64.0) 15 (34.9) 1.0 (Reference)
C/T 28 (32.6) 21 (48.8) 4.8 (1.65–13.83) 0.004
C/C 3 (3.5) 7 (16.3) 11.2 (2.27–55.37) 0.003
C carrier§ 31 (36.0) 28 (65.1) 5.6 (2.02–15.51) 0.001
IL-1RN
L/L 30 (34.9) 13 (31.0) 1.0 (Reference)
*2/L 46 (53.5) 21 (50.0) 1.0 (0.44–2.34) 0.98
*2/*2 10 (11.6) 8 (19.0) 1.6 (0.48–5.39) 0.43
*2 carrier¶ 56 (65.1) 29 (69.0) 1.1 (0.50–2.48) 0.79
when heterozygosity was associated with these pathologies 
(OR, 4.79 and 2.17, respectively). 
 Our results agree with reports from Asia 16–18 that also showed 
higher GC risk for subjects with the  IL-1B -511 C allele. In 
addition, Ikehara and others 19 reported that the C allele was 
associated with progression of gastric cancer, and Matsukura 
and others 20 found that the  IL-1B -511 C/C genotype was more 
prevalent in Japanese subjects with severe mucosal atrophy. In 
contrast, previous studies have reported that the  IL-1B -511 T 
allele and the  IL-1RN *2 allele are associated with ChAG or 
GC in Caucasians. 21–24 The results of the  IL-1B -511 C allele 
risk association are very interesting, because four meta-
analyses 25–28 did not reveal concurrent evidence for the  IL-1B -
511 T allele, and significant associations between  IL-1B SNP 
and GC were only found for Caucasians. 
 Differences in GC prevalence,  H. pylori infection, allele fre-
quency, and ethnicity might account for the varied results found 
in Caucasian and Asian populations. This theory is supported 
by a study from China that showed a significant risk associated 
with  IL-1B -511 only for the population where gastric cancer 
was less prevalent. 29 Rates of GC and  H. pylori infection in 
Peru are among the highest in the world. 13,30 Moreover, the 
T allele frequency for control patients in our study popula-
tion (T allele frequency = 0.8) is higher than that reported in 
Caucasians (T allele frequency ~0.3) and Asians (T allele fre-
quency ~0.46). Our data agrees with previous data that have 
shown that variation of several factors might affect gene poly-
morphism associations. 20,29 
 Previous studies from Peru have shown that ChAG is found 
predominantly in the antrum region and is more severe than 
ChAG that is found in the body of the stomach. 31–33 In the 
present study, we also found ChAG to occur more frequently 
in the antrum region, and only in this gastric site was an asso-
ciation between ChAG and the C allele statistically significant. 
However, conflicting results regarding mucosal  IL-1b levels 
and the  IL-1B -511 SNP indicate that this association is depen-
dent on the study population. 8,34,35 
 Our stratification analysis for the effects of the  IL-1B allele 
type on the subtype and location of GC reflected an increased 
risk for intestinal types of GC in the corpus (OR, 6.29) and 
for  IL-1B -511 C allele homozygosity. In line with these find-
ings, Uemura and others 3 reported that patients with  H. pylori 
infection, predominantly in the corpus, were at a significantly 
higher risk for intestinal gastric cancer. This finding empha-
sizes the importance of chronic atrophic gastritis and how its 
site of occurrence is affected by previous  H. pylori infection. 
 Taken together, the C allele has been associated with higher 
 IL-1B promoter activity and thus with  IL-1b synthesis. 36 In 
 Table 3 
 Hardy Weinberg Equilibrium (HWE) for matched cases and controls 
 *  Controls and cases are matched 2:1 for age, sex, and environmental factors. 
 **  Controls and cases are matched 1:1 for age, sex, and environmental factors. 
 †  Nonatrophic gastritis. 
 ‡  Chronic atrophic gastritis. 
 §  Gastric cancer. 
 ^ *  Fisher’s test. 
 # Observed . 
 ¶  Expected . 
Hardy Weinberg equilibrium
Patients for ChAG risk analysis Patients for GC risk analysis
NAG*† ChAG*‡ NAG** GC**§
Genotype Obs. no.# (exp.)¶  P value^ Obs. (exp.)  P value Obs. (exp.)  P value Obs. (exp.)  P value
 IL-1B-511 
C/C 3 (3.36) 7 (7.12) 7 (6.54) 15 (15.91)
C/T 28 (27.28) 21 (20.76) 45 (45.91) 62 (60.18)
T/T 55 (55.36) 1.0 15 (15.12) 1.0 81 (80.54) 0.8 56 (56.91) 0.85
 IL-1RN 
*2/*2 10 (12.66) 8 (8.15) 16 (18.80) 16 (19.94)
*2/L 46 (40.67) 21 (20.70) 68 (62.41) 71 (63.12)
L/L 30 (32.66) 0.26 13 (13.15) 1.0 49 (51.80) 0.36 46 (49.94) 0.2
 Table 5 
 Conditional logistic regression analysis for the risk of gastric cancer 
using nonatrophic gastritis subjects as control 
 Controls and cases are matched 1:1 for age, sex, and environmental factors. 
 *  Nonatrophic gastritis (controls). 
 †  Gastric cancer (cases). 
 ‡  Conditional logistic regression model adjusted for  H. pylori infection. 
 §  Subjects with genotype C/T or C/C. 
 ¶  Subjects with genotype *2/L or *2/*2. 
NAG* GC†
Genotype  n (%)  n (%) OR (95% CI)‡  P value‡
IL-1B-511
T/T 81 (60.9) 56 (42.1) 1.0 (Reference)
C/T 45 (33.8) 62 (46.6) 2.17 (1.23–3.84) 0.007
C/C 7 (5.3) 15 (11.3) 4.15 (1.33–12.93) 0.014
C carrier§ 52 (39.1) 77 (57.9) 2.36 (1.36–4.11) 0.002
IL-1RN
L/L 49 (36.8) 46 (34.6) 1.0 (Reference)
*2/L 68 (51.1) 71 (53.4) 1.03 (0.59–1.80) 0.91
*2/*2 16 (12.0) 16 (12.0) 0.86 (0.34–2.14) 0.75
*2 carrier¶ 84 (63.2) 87 (65.4) 0.99 (0.57–1.71) 0.99
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terms of possible mechanisms for GC risk in Peruvians, the 
increased  IL-1b mucosal levels might cause profound inhibi-
tion of gastric acid secretion, which makes the gastric corpus 
(where most parietal cells are located) more hospitable for 
 H. pylori colonization after initial infection in the antrum. 37,38 
Local infection-induced inflammation in the corpus can exac-
erbate the elevated  IL-1b levels and thereby increase gastric 
mucosal pH, which paves the way for a progression of prema-
lignant mucosal changes. 39 We propose that these bacterial-host 
synergisms explain the strong 511 C allele SNP gastric cancer 
association reported here in our results. The fact that the  IL-1B -
511 C allele was not associated with an increased risk for the 
diffuse-subtype GC suggests a different pattern for the emer-
gence of or at least a lower correlation to atrophy in gastric 
mucosa. 
 Further study is needed on the polymorphic  IL-10 gene’s 
affect regarding the occurrence of premalignant lesions and 
GC in Peruvians.  IL-10 serves as a counter balance in the 
inflammatory orchestra and antagonizes proinflammatory 
cytokines, especially  IL-1b . 40 The low  IL-10 haplotype ( IL-10-
1082A, IL-10-819T, and  IL-10-592A ) has been reported to sig-
nificantly increase the risk of noncardia gastric cancer, most 
likely by uncontrolled  IL-1b activity causing a hyperinflam-
matory milieu. 21 However, similar to  IL-1B, contradictory data 
exist for the reported polymorphism in the  IL-10 gene. 41 
 Our  IL-1RN polymorphism analyses did not show any 
significant association between *2 allele and gastric disease. 
This contrasts with several studies in Caucasian populations 
in which the risk of GC was associated with the presence of 
the  IL-1RN *2 allele. 21–23,42,43 The  IL-1RN *2 allele has been 
reported with elevated  IL-1ra levels and thereby with higher 
 IL-1b levels in  in-vitro cell cultures. 44  Helicobacter pylori viru-
lence, other environmental factors, or human genetic factors 
may diminish the importance of these  IL-1ra variants as regu-
lators of  IL-1B receptor binding in the Peruvian population. 
 In conclusion, our study is the first to establish the C allele 
of the  IL-1B -511 SNP as a risk factor for intestinal-type 
GC and its premalignant lesion, gastric atrophy, in a largely 
Amerindian population. These findings are consistent with the 
progression of histologic changes from chronic atrophic gas-
tritis to intestinal types of GC and furthermore suggest differ-
ences in the processes leading to diffuse types of GC. 
 Our findings support the theory that inter-individual geneti-
cally determined differences of cytokine production affect 
outcomes in  H. pylori infection and GC. 45,46 
 In view of a high  H. pylori prevalence and a high recurrence 
rate of treated infections in Peruvians, 13  IL-1B -511 SNP might 
be an indicator of which patients would benefit from rigorous 
anti- H. pylori therapy and vigilant surveillance of their gastric 
mucosal changes by intermittent gastroscopies. 
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 Risk of getting ChAG or GC in subjects that are homozygous carriers of the IL-1B-511C allele by anatomic location 
 *  Subjects with genotype C/C and C/T. 
 †  Unconditional logistic regression model adjusted for  H. pylori infection. 
 ‡  Nonatrophic gastritis. 
 §  n (%). 
 ¶  Chronic atrophic gastritis. 
 ^   Intestinal-type gastric cancer. 
 **  Diffuse-type gastric cancer. 
IL-1B-511 genotype C/C vs. T/T C carrier* vs. T/T
Location Matched pairs C/C C/T C carrier T/T OR (95% CI)†  P value† OR (95% CI)†  P value†
Control NAG‡ 12 (13.3)§ 21 (34.4) 23 (37.7) 38 (62.3)
Cases ChAG¶ 16 (16.7) 19 (52.8) 25 (69.4) 11 (30.6) 12.72 (2.1–76.4) 0.005 4.00 (1.6–9.8) 0.002
Antrum Control NAG 15 (15.3) 32 (33.7) 37 (38.9) 58 (61.1)
Cases GC 13 (14.3) 36 (51.4) 39 (55.7) 31 (44.3) 11.07 (0.2–4.8) 0.93 1.96 (1.0–3.7) 0.038
IT-GC^ 12 (14.0) 25 (50.0) 27 (54.0) 23 (46.0) 11.03 (0.2–5.8) 0.97 1.85 (0.9–3.8) 0.087
DT-GC** 11 (15.0) 11 (55.0) 12 (60.0) 18 (40.0) 11.30 (0.1–13.2) 0.82 2.36 (0.9–6.3) 0.089
Control NAG 11 (14.0) 17 (28.0) 18 (32.0) 17 (68.0)
Cases ChAG 11 (14.3) 12 (28.6) 13 (42.9) 14 (57.1) 4.84 (0.1–360.6) 0.47 1.23 (0.1–12.6) 0.86
Corpus Control NAG 12 (15.3) 13 (34.2) 15 (39.5) 23 (60.5)
Cases GC 12 (19.0) 26 (41.3) 38 (60.3) 25 (39.7) 5.56 (1.1–29.0) 0.034 2.46 (1.1–5.7) 0.037
IT-GC 19 (21.4) 17 (40.5) 26 (61.9) 16 (38.1) 6.29 (1.2–33.8) 0.032 2.60 (1.0–6.5) 0.042
DT-GC 13 (14.3) 19 (42.9) 12 (57.1) 19 (42.9) 5.00 (0.7–37.3) 0.116 2.27 (0.7–7.0) 0.155
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